ASML vs BEAM · P/E 57, $665.37B cap vs rev $63.5M
ASML Holding NV ADR (ASML) versus Beam Therapeutics Inc (BEAM) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. BEAM currently screens at market cap $2.01B.
Not investment advice. Open the ASML and BEAM stock pages for the full models.
Not investment advice.